Device, system and method for intermittent displacement of blood to mitigate peripheral nerve neuropathy
Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.
1. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device; and
communicating an electrical signal through the body part for causing forced-diffusion of an oxygen-carrying compression-inducing medium therethrough, wherein the oxygen-carrying compression-inducing medium provides negatively charged nano oxygen bubbles and wherein communicating the electrical signal comprises said electrical signal being provided to an electrode of the compression exertion device to cause the negatively charged nano oxygen bubbles to be repelled away from the electrode and to be pushed into the epidermis skin layer.
2. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device having a wall at least partially defining the interior space, wherein delivering the compression-inducing medium includes delivering the compression-inducing medium into the interior space of the compression exertion device, wherein the compression-inducing medium is an oxygen-carrying medium capable of diffusing oxygen into at least one of the epidermis tissue and dermis tissue of the body part, and wherein exerting the compressive pressure on the body part includes:
maintaining a current volume of the oxygen-carrying medium under pressure within the interior space of the compression exertion device for at least one of a first designated period of time and until a level of oxygen in the oxygen-carrying medium decreases below a prescribed threshold level;
removing at least a portion of the current volume of oxygen-carrying medium during said administering of the chemotherapeutic agent;
delivering a replacement volume of oxygen-carrying medium into the interior space of the compression exertion device after removing the at least a portion of the current volume of oxygen-carrying medium to create a new volume of the oxygen-carrying medium within the interior space of the compression exertion device; and
pressurizing the new volume of oxygen-carrying medium to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part.
3. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device having a wall at least partially defining the interior space, wherein delivering the compression-inducing medium includes delivering the compression-inducing medium into the interior space of the compression exertion device, wherein the compression-inducing medium is an oxygen-carrying medium capable of diffusing oxygen into the epidermal and dermis tissue of the body part, wherein the compression exertion device includes an expansion cavity at least partially surrounding the interior space of the compression exertion device, wherein exerting the compressive pressure on the body part of the patient during at least a portion of the prescribed amount of delivery includes causing pressurized delivery of the compression-inducing medium into the expansion cavity of the compression exertion device, and wherein exerting the compressive pressure is initiated prior to said administering of the chemotherapeutic agent and wherein administering the chemotherapeutic agent is initiated after blood flow into dermis tissue of the body part is at least one of occluded and reduced.
4. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device having a wall at least partially defining the interior space, wherein delivering the compression-inducing medium includes delivering the compression-inducing medium into the interior space of the compression exertion device, wherein the compression-inducing medium is an oxygen-carrying medium capable of diffusing oxygen into the epidermal and dermis tissue of the body part, wherein the compression exertion device includes an expansion cavity at least partially surrounding the interior space of the compression exertion device, wherein exerting the compressive pressure on the body part of the patient during at least a portion of the prescribed amount of delivery includes causing pressurized delivery of the compression-inducing medium into the expansion cavity of the compression exertion device, and;
releasing at least a portion of said compressive pressure after said administering of the chemotherapeutic agent is initiated; and
reapplying said compressive pressure after blood flow is resumed through the body part for at least a designated duration of time.
5. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device having an outer enclosure during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device having a wall at least partially defining the interior space, and wherein exerting the compressive pressure on the body part includes providing an expansion limiting impediment to impede outward expansion of the outer enclosure.
6. A method for mitigating peripheral nerve neuropathy associated with chemotherapy treatment, comprising:
exerting a compressive pressure on a body part of a patient positioned within an interior space of a compression exertion device during administration of at least a portion of a prescribed amount of delivery of a chemotherapeutic agent to the patient, wherein the compressive pressure is exerted for causing at least one of a magnitude of the compressive pressure and a duration of time for said compressive pressure being exerted to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part, wherein exerting the compressive pressure on the body part includes delivering a compression-inducing medium into at least one of the interior space of the compression exertion device and an expansion cavity of the compression exertion device having a wall at least partially defining the interior space, and wherein exerting the compressive pressure on the body part includes exerting the compressive pressure using a sealing component of the pressure exertion device engageable with at least one of a portion of the body part and a limb to which the body part is attached when the body part is positioned within the interior space.
7. The method of claim 4 , further comprising:
diffusing dissolved oxygen within an aqueous compression inducing medium into epidermis tissue of the body part;
wherein at least a portion of said diffusing and at least a portion of said exerting are performed simultaneously.
8. The method of claim 4 , further comprising:
diffusing negatively charged nano oxygen bubbles within an aqueous compression inducing medium into epidermis tissue of the body part; and
wherein at least a portion of said diffusing and at least a portion of said exerting are performed simultaneously.
9. The method of claim 4 wherein:
exerting the compressive pressure is initiated prior to said administering of the chemotherapeutic agent; and
administering the chemotherapeutic agent is initiated after blood flow into dermis tissue of the body part is at least one of occluded and reduced.
10. The method of claim 9 , further comprising:
releasing at least a portion of said compressive pressure after said administering of the chemotherapeutic agent is initiated; and
reapplying said compressive pressure after blood flow is resumed through the body part for a designated duration of time.
11. The method of claim 4 wherein exerting the compressive pressure on the body part includes pressurizing a compression-inducing medium surrounding the body part.
12. The method of claim 11 wherein the compression-inducing medium comprises a negatively-charged nano oxygen bubbles in an aqueous solution.
13. The method of claim 1 , wherein:
a wall of the compression exertion device at least partially defines the interior space of the compression exertion device; and
the wall comprises the electrode.
14. The method of claim 1 , further comprising:
prior to or in combination with the body part becoming positioned within the interior space of the compression excretion devise, altering one or more physical attribute of the stratum corium of the tissue of the body part for promoting transfer of gaseous and/or liquid material therethrough.
15. The method of claim 14 wherein:
said altering of the stratum corium includes soaking the body part in an aqueous solution of water comprising a penetration enhancer for a period of time prior to commencement of said exerting the compressive pressure to enable an oxygen flowable medium to deliver oxygen into the tissue of the body part; and
the penetrating enhancer comprises water having nano-sized oxygen bubbles therein.
16. The method of claim 14 wherein said altering one or more physical attribute of the stratum corium includes performing said altering using at least one of adhesive tape stripping, micro-punctures, micro dermal abrasions and chemical peels.
17. The method of claim 2 wherein:
the compression exertion device includes an expansion cavity at least partially surrounding the interior space of the compression exertion device; and
exerting the compressive pressure on the body part of the patient during at least a portion of the prescribed amount of delivery includes causing pressurized delivery of the compression-inducing medium into the expansion cavity of the compression exertion device.
18. The method of claim 4 , further comprising:
prior to exerting the compressive pressure and administering the chemotherapeutic agent to the patient, providing in the interior space of the compression exertion device an initial volume of oxygen-carrying medium capable of diffusing oxygen into the epidermis tissue of the body part.
19. The method of claim 18 wherein said oxygen-carrying medium comprises negatively-charged, nano-sized oxygen bubbles.
20. The method of claim 18 wherein:
the initial volume of oxygen-carrying medium is a self-contouring pressure distribution article that uniformly applies compressive pressure onto irregular surfaces of the body part; and
delivering the compression-inducing medium into the expansion cavity of the compression exertion device causes a cavity partition defining the expansion cavity to exert compressive force on the initial volume of oxygen-carrying medium around substantially an entire surface area of the body part.
21. The method of claim 18 wherein exerting the compressive pressure on the body part includes:
maintaining the initial volume of the oxygen-carrying medium under pressure for at least one of a first designated period of time and until a level of oxygen in the initial volume of oxygen-carrying medium decreases below a prescribed threshold level;
removing at least a portion of the initial volume of oxygen-carrying medium during said administering of the chemotherapeutic agent;
delivering a replacement volume of oxygen-carrying medium into the interior space of the compression exertion device after removing the at least a portion of the initial volume of oxygen-carrying medium to create a new volume of the oxygen-carrying medium within the interior space of the compression exertion device; and
pressurizing the new volume of oxygen-carrying medium sufficient to at least one of occlude blood flow into dermis tissue of the body part and reduce blood flow into dermis tissue of the body part.
22. The method of claim 5 wherein exerting the compressive pressure on the body part includes cycling the compressive pressure between a first designated pressure and a second designated pressure higher than the first designated pressure.
23. The method of claim 5 wherein exerting the compressive pressure on the body part includes thermally conditioning the compression-inducing medium to a temperature-controlled and regulated pressure to be impinged upon the body part of the patient.
24. The method of claim 6 wherein exerting the compressive pressure on the body part is performed for exerting a designated amount of thermally conditioned, equally distributed and controlled blood displacing compression pressure on the body part.
25. The method of claim 6 , wherein the compression-inducing medium comprises one or more oxygen charged perfluorocarbon compositions.
26. The method of claim 18 wherein exerting the compressive pressure on the body part includes thermally conditioning the compression-inducing medium to a temperature-controlled and regulated pressure to be impinged upon the body part.
27. The method of claim 6 wherein exerting the compressive pressure on the body part includes thermally conditioning the compression-inducing medium to a temperature-controlled and regulated pressure to be impinged upon the body part.
28. The method of claim 18 wherein exerting the compressive pressure on the body part is performed for exerting a designated amount of thermally conditioned, equally distributed and controlled blood displacing compression pressure on the body part.
29. The method of claim 5 wherein exerting the compressive pressure on the body part is performed for exerting a designated amount of thermally conditioned, equally distributed and controlled blood displacing compression pressure on the body part.
30. The method of claim 18 wherein the compression-inducing medium comprises one or more oxygen charged perfluorocarbon compositions.
31. The method of claim 5 wherein the compression-inducing medium comprises one or more oxygen charged perfluorocarbon compositions.